Definitive Contract 75D30122C13322
Award Date 3/7/22
Potential Completion Date 12/11/23
Potential Value $2.8M
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burlington, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
- Laboratory Corporation of America Holdings, doing business as Labcorp, has been awarded a definitive contract valued at $4.19 million by the Centers for Disease Control and Prevention to conduct an Assessment of SARS-CoV-2 Seroprevalence and Immune Responses. The contract is a firm fixed price agreement for Labcorp to perform seroprevalence studies and analyze immune responses to COVID-19 in Burlington, North Carolina over an eight-month period ending in February 2022. No subcontractors or set...
- The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
- Laboratory Corporation of America (LabCorp) has been awarded a firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The contract value is $27.94 million to provide SARS-COV-2 SPHERES BASELINE GENOMIC SEQUENCING. No set aside designation was specified. As the prime contractor, LabCorp will deliver genomic sequencing services in support of the CDC's efforts to track variations in the SARS-COV-2 virus. LabCorp operates...
- Laboratory Corporation of America Holdings has been awarded a $533,990 firm fixed price delivery order by the Centers for Disease Control and Prevention in Pittsburgh for surge serology testing in support of coronavirus COVID-19 efforts. The contract runs from January 14, 2021 through April 26, 2021 and will see Laboratory Corporation perform serology testing services from its location in Burlington, North Carolina. No subcontractors or set aside designations were specified. This delivery...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Laboratory Corporation of America (Labcorp), a leading global life sciences company. The contract is part of a larger multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) vehicle called the "TEST SURGE MULTIPLE AWARD IDIQ," which has a total ceiling value of $4,286,480.04. The contract is a firm-fixed-price delivery order with a period of performance ending on September...
- The Centers for Disease Control and Prevention (CDC) awarded Laboratory Corporation of America (Labcorp) a definitive firm fixed-price contract valued at $91.69M for COVID-19 laboratory testing services, with an ultimate completion date of April 22, 2025. The contract, which was awarded on May 16, 2022, operates as a child contract without small business set-aside provisions and is performed at Labcorp's facility in Burlington, North Carolina. This award represents the federal government's...
- This is a $13,031,850.00 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp) for genomic sequencing services. The contract has an ultimate completion date of May 14, 2022 and was awarded on December 26, 2021. LabCorp is a leading global life sciences company that provides diagnostic information services. They have extensive experience contracting with the federal government, including through their...
- This is a $75,750 delivery order contract awarded to Laboratory Corporation of America (Labcorp) by the Centers for Disease Control and Prevention (CDC) Pittsburgh for the "H5 TEST CREATION TASK ORDER". The contract is not set aside and is issued under the parent "Test Surge and Data Sharing" Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Labcorp, a leading global life sciences company, provides comprehensive diagnostic testing services to the federal government,...
- The U.S. Department of the Army Medical Command awarded a firm fixed price delivery order contract for $300,074.75 to Laboratory Corporation of America (LabCorp), a leading global life sciences company, for clinical reference laboratory testing services. This contract was not set aside and does not appear to be part of a larger contracting vehicle. LabCorp has been awarded numerous federal contracts to provide medical laboratory testing and analysis services in support of government healthcare...